MEDICINE & HEALTHSupplementation with Curcugen® from Dolcas Biotech delivered clinically significant improvements in knee pain and performance-based tests in a randomized, double-blind, placebo-controlled study.
Experts used nanotechnology to develop a solution against antibiotic-resistant infection, a disease in which treatments kill bacteria along with health human cells.
A team of researchers led by Dr. WANG Liping from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences recently reported a common circuit that regulates both innate fear and rapid eye movement (REM) sleep.
Some people are accusing Ethereum co-founder Vitalik Buterin and other rich tech guys, such as Elon Musk, to be building "The Matrix" for suggesting artificial wombs could ease the pregnancy on women.
New research recently found that a new mobile app boosts the confidence of parents while caring for their babies, and it continues to help them up to a whole month after leaving the hospital.
A new study revealed the uptake pathways of nano- and microplastics in edible plants and quantified the accumulation of plastic particles in plants that are served as salads.
A new study reveals that COVID-19 vaccines are completely unrelated to infertility rates of both partners, regardless if whether they are vaccinated or not.
Researchers found that the anticoagulant heparin could help treat COVID-19 patients as it improves symptoms and increase oxygen levels in the lungs by about 70%.
RT-PCR test may be considered the gold standard of testing, but there is also a time and place for a rapid antigen test. Here's when each test is best to use.
As more and more people are getting their COVID-19 vaccine, many have started to wonder if they should take a painkiller and if so, if it should be taken before or after the jab.
The main investor in the additional financing round was Butterfly Ventures, which had previously invested in the company. Also, Tesi (Finnish Industry Investment Ltd) and earlier shareholders participated in it. With the new capital, the company aims for even faster growth and development.